Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
Clinical trial NCT05659251 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05659251
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2024-10-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.